Table 3.
HRSA clinical performance measure scores among CHCs with and without at least one designated delivery site
| Percentage score | No. of CHCs that met/exceeded benchmark (%) | |||||
|---|---|---|---|---|---|---|
| No designated sites | With designated sites | p value | No designated sites | With designated sites | p value | |
| Perinatal health | ||||||
| Access to prenatal care (≥ 88.1%)a | 61.1 | 68.0 | 0.001 | 22 (8.4) | 107 (13.8) | 0.023 |
| Low birth weight (≤ 6.8%)a | 10.1 | 9.0 | 0.119 | 154 (58.8) | 362 (46.6) | < 0.0001 |
| Preventive health screening & services | ||||||
| Cervical cancer screening (≥ 55.7%) | 45.3 | 53.5 | < 0.0001 | 70 (26.7) | 370 (47.6) | < 0.0001 |
| Weight assessment & counseling (children) (≥ 65.9%) | 56.1 | 67.1 | < 0.0001 | 110 (42.0) | 444 (57.1) | < 0.0001 |
| Weight assessment & counseling (adults) (≥ 63.9%) | 63.9 | 70.0 | 0.000 | 142 (54.2) | 486 (62.6) | 0.017 |
| Colorectal cancer screening (≥ 42.0%) | 35.8 | 43.6 | < 0.0001 | 89 (34.0) | 405 (52.1) | < 0.0001 |
| Childhood immunization status (≥ 80%)a | 32.2 | 34.7 | 0.145 | 15 (5.7) | 14 (1.8) | 0.001 |
| Chronic disease management | ||||||
| Use of appropriate medications for asthma (≥ 86.6%) | 72.8 | 83.2 | < 0.0001 | 109 (41.6) | 442 (56.9) | < 0.0001 |
| Coronary artery disease: lipid therapy (≥ 80.7%) | 73.1 | 80.4 | < 0.0001 | 129 (49.2) | 451 (58.0) | 0.013 |
| IVD: use of aspirin or another antithrombotic (≥ 79.3%) | 72.3 | 81.0 | < 0.0001 | 125 (47.7) | 506 (65.1) | < 0.0001 |
| Controlling high blood pressure (hypertensive) (≥ 61.2%)a | 58.9 | 63.2 | < 0.0001 | 119 (45.4) | 466 (60.0) | < 0.0001 |
aIndicates a Healthy People 2020 Benchmark
Note: HRSA performance benchmarks are shown in parentheses